Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Current and novel therapies for management of Acinetobacter baumannii -associated pneumonia

1 Jul 2024

Abstract excerpt

Acinetobacter baumannii is a common pathogen associated with hospital-acquired pneumonia showing increased resistance to carbapenem and colistin antibiotics nowadays. Infections with A. baumannii cause high patient fatalities due to their capability to evade current antimicrobial therapies, emphasizing the urgency of developing viable therapeutics to treat A. baumannii-associated pneumonia. In this review, we...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibiotic Resistance in Bacteria
Share to Burkholderia infections and melioidosis
Share to Vibrio bacteria research studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 38949254
DOI: 10.1080/1040841x.2024.2369948

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Current and novel therapies for management of Acinetobacter baumannii -associated pneumoniaPMID 38949254Read ↗

Clinical treatment of hospital-acquired pneumonia caused by extensively drug-resistant Acinetobacter baumannii: single-centre retrospective studySemantic proximity Read ↗

Tug of war betweenAcinetobacter baumanniiand host immune responsesSemantic proximity Read ↗

Management of PneumoniaSemantic proximity Read ↗

An Update of Peptides With Therapeutic Potential Against <em>Acinetobacter baumannii </em>InfectionsSemantic proximity Read ↗

Antibiotic resistance of pathogenic Acinetobacter species and emerging combination therapySemantic proximity Read ↗

Colistin Resistance Mechanism and Management Strategies of Colistin-Resistant Acinetobacter baumannii InfectionsSemantic proximity Read ↗

Antibiotics and non-traditional antimicrobial agents for carbapenem-resistant Acinetobacter baumannii in Phase 1, 2, and 3 clinical trialsSemantic proximity Read ↗

Targeted treatment for bacterial infections: prospects for pathogen-specific antibiotics coupled with rapid diagnosticsSemantic proximity Read ↗

Colistin Resistance Mechanism and Management Strategies of Colistin-Resistant <em>Acinetobacter baumannii</em> InfectionsSemantic proximity Read ↗

A hypervirulent Acinetobacter baumannii strain has robust anti- phagocytosis abilitySemantic proximity Read ↗

Development of Antimicrobial Agents in the Era of New and Reemerging Infectious Diseases and Increasing Antibiotic ResistanceSemantic proximity Read ↗

Potentially effective antimicrobial treatment for pneumonia caused by isolates of carbapenem-resistant and extensively drug-resistant Acinetobacter baumannii complex species: what can we expect in the future?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.